| Name | Section 216: Advanced Pharmacogenomics and Precision Therapeutics for CBS/PSP |
| Summary | Advanced pharmacogenomic applications including polygenic risk scores, pharmacometabolomics, epigenetic modifiers, gene expression biomarkers, microbiome interactions, and implementation science for CBS/PSP precision medicine |